Abe M, Onji M. Natural history of primary biliary cirrhosis. Hepatol Res. 2008;38:639–45.
Article
PubMed
Google Scholar
Heathcote EJ. Management of primary biliary cirrhosis. The American Association for the Study of Liver Diseases practice guidelines. Hepatology. 2000;31:1005–13.
CAS
Article
PubMed
Google Scholar
Silveira MG, Suzuki A, Lindor KD. Surveillance for hepatocellular carcinoma in patients with primary biliary cirrhosis. Hepatology. 2008;48:1149–56.
Article
PubMed
Google Scholar
Bruix J, Sherman M. Management of hepatocellular carcinoma. Hepatology. 2005;42:1208–36.
Article
PubMed
Google Scholar
Nakamura M, Kondo H, Mori T, Komori A, Matsuyama M, Ito M, et al. Anti-gp210 and anti-centromere antibodies are different risk factors for the progression of primary biliary cirrhosis. Hepatology. 2007;45:118–27.
CAS
Article
PubMed
Google Scholar
Cavazza A, Caballería L, Floreani A, Farinati F, Bruguera M, Caroli D, et al. Incidence, risk factors, and survival of hepatocellular carcinoma in primary biliary cirrhosis: comparative analysis from two centers. Hepatology. 2009;50:1162–8.
Article
PubMed
Google Scholar
Allen RA, Lisa JR. Combined liver cell and bile duct carcinoma. Am J Pathol. 1949;25:647–55.
CAS
PubMed
PubMed Central
Google Scholar
Zuckerman E, Misselevich I, Boss JH. Oval cell hyperplasia in asparaginase: induced liver damage. Liver. 2002;22:363–4.
CAS
Article
PubMed
Google Scholar
Kofman AV, Morgan G, Kirschenbaum A, Osbeck J, Hussain M, Swenson S, et al. Dose- and time-dependent oval cell reaction in acetaminophen-induced murine liver injury. Hepatology. 2005;41:1252–61.
CAS
Article
PubMed
Google Scholar
Tan J, Hytiroglou P, Wieczorek R, Park YN, Thung SN, Arias B, et al. Immunohistochemical evidence for hepatic progenitor cells in liver diseases. Liver. 2002;22:365–73.
Article
PubMed
Google Scholar
Theise ND, Yao JL, Harada K, Hytiroglou P, Portmann B, Thung SN, et al. Hepatic ‘stem cell’ malignancies in adults: four cases. Histopathology. 2003;43:263–71.
CAS
Article
PubMed
Google Scholar
Komuta M, Spee B, Vander Borght S, De Vos R, Verslype C, Aerts R, et al. Clinicopathological study on cholangiocellular carcinoma suggesting hepatic progenitor cell origin. Hepatology. 2008;47:1544–56.
CAS
Article
PubMed
Google Scholar
Primary liver cancer in Japan. Clinicopathologic features and results of surgical treatment. Liver Cancer Study Group of Japan. Ann Surg. 1990;211:277–87.
Google Scholar
Zhou YM, Yang JM, Wang B, Xu F, Tong Y, Li DQ. Combined hepatocellular carcinoma and cholangiocarcinoma: a case report and review of the literature. Hepatobiliary Pancreat Dis Int. 2007;6:656–9.
PubMed
Google Scholar
Kim H, Park C, Han KH, Choi J, Kim YB, Kim JK, et al. Primary liver carcinoma of intermediate (hepatocyte–cholangiocyte) phenotype. J Hepatol. 2004;40:298–304.
CAS
Article
PubMed
Google Scholar
Yamamoto S, Kubo S, Hai S, Uenishi T, Yamamoto T, Shuto T, et al. Hepatitis C virus infection as a likely etiology of intrahepatic cholangiocarcinoma. Cancer Sci. 2004;95:592–5.
CAS
Article
PubMed
Google Scholar
Mishra L, Banker T, Murray J, Byers S, Thenappan A, He AR, et al. Liver stem cells and hepatocellular carcinoma. Hepatology. 2009;49:318–29.
Article
PubMed
PubMed Central
Google Scholar
Yamashita T, Ji J, Budhu A, Forgues M, Yang W, Wang HY, et al. EpCAM-positive hepatocellular carcinoma cells are tumor-initiating cells with stem/progenitor cell features. Gastroenterology. 2009;136:1012–24.
CAS
Article
PubMed
Google Scholar
Okuda H, Shiratori K, Yamamoto M, Takasaki K, Nakano M. Clinicopathologic features of patients with intrahepatic cholangiocarcinoma who are seropositive for alpha-fetoprotein-L3 and those with combined hepatocellular and cholangiocarcinoma. J Gastroenterol Hepatol. 2006;21:869–73.
CAS
Article
PubMed
Google Scholar
Nakamura S, Suzuki S, Sakaguchi T, Serizawa A, Konno H, Baba S, et al. Surgical treatment of patients with mixed hepatocellular carcinoma and cholangiocarcinoma. Cancer. 1996;78:1671–6.
CAS
Article
PubMed
Google Scholar
Nagaoka S, Itano S, Ishibashi M, Torimura T, Baba K, Akiyoshi J, et al. Value of fusing PET plus CT images in hepatocellular carcinoma and combined hepatocellular and cholangiocarcinoma patients with extrahepatic metastases: preliminary findings. Liver Int. 2006;26:781–8.
Article
PubMed
Google Scholar
Tang D, Nagano H, Nakamura M, Wada H, Marubashi S, Miyamoto A, et al. Clinical and pathological features of Allen’s type C classification of resected combined hepatocellular and cholangiocarcinoma: a comparative study with hepatocellular carcinoma and cholangiocellular carcinoma. J Gastrointest Surg. 2006;10:987–98.
Article
PubMed
Google Scholar